267 related articles for article (PubMed ID: 23801672)
1. Direct cellular reprogramming in Caenorhabditis elegans: facts, models, and promises for regenerative medicine.
Zuryn S; Daniele T; Jarriault S
Wiley Interdiscip Rev Dev Biol; 2012; 1(1):138-52. PubMed ID: 23801672
[TBL] [Abstract][Full Text] [Related]
2. Cell plasticity in Caenorhabditis elegans: from induced to natural cell reprogramming.
Hajduskova M; Ahier A; Daniele T; Jarriault S
Genesis; 2012 Jan; 50(1):1-17. PubMed ID: 21932439
[TBL] [Abstract][Full Text] [Related]
3. Natural and induced direct reprogramming: mechanisms, concepts and general principles-from the worm to vertebrates.
Becker SF; Jarriault S
Curr Opin Genet Dev; 2016 Oct; 40():154-163. PubMed ID: 27690213
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming and transdifferentiation shift the landscape of regenerative medicine.
Guo J; Wang H; Hu X
DNA Cell Biol; 2013 Oct; 32(10):565-72. PubMed ID: 23930590
[TBL] [Abstract][Full Text] [Related]
5. The multipotency-to-commitment transition in Caenorhabditis elegans-implications for reprogramming from cells to organs.
Spickard EA; Joshi PM; Rothman JH
FEBS Lett; 2018 Mar; 592(6):838-851. PubMed ID: 29334121
[TBL] [Abstract][Full Text] [Related]
6. FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells.
Kolundzic E; Ofenbauer A; Bulut SI; Uyar B; Baytek G; Sommermeier A; Seelk S; He M; Hirsekorn A; Vucicevic D; Akalin A; Diecke S; Lacadie SA; Tursun B
Dev Cell; 2018 Sep; 46(5):611-626.e12. PubMed ID: 30078731
[TBL] [Abstract][Full Text] [Related]
7. Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps.
Richard JP; Zuryn S; Fischer N; Pavet V; Vaucamps N; Jarriault S
Development; 2011 Apr; 138(8):1483-92. PubMed ID: 21389048
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine.
Pesaresi M; Sebastian-Perez R; Cosma MP
FEBS J; 2019 Mar; 286(6):1074-1093. PubMed ID: 30103260
[TBL] [Abstract][Full Text] [Related]
9. Strategies for in vivo reprogramming.
Ofenbauer A; Tursun B
Curr Opin Cell Biol; 2019 Dec; 61():9-15. PubMed ID: 31323468
[TBL] [Abstract][Full Text] [Related]
10. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
Sanges D; Lluis F; Cosma MP
Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
12. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
Ebrahimi B
Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
[TBL] [Abstract][Full Text] [Related]
14. [Reprogramming of somatic cells. Problems and solutions].
Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
[TBL] [Abstract][Full Text] [Related]
15. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
16. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
17. Chemical transdifferentiation: closer to regenerative medicine.
Xu A; Cheng L
Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989
[TBL] [Abstract][Full Text] [Related]
18. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
20. Toward transgene-free induced pluripotent stem cells: lessons from transdifferentiation studies.
Chua SJ; Casper RF; Rogers IM
Cell Reprogram; 2011 Aug; 13(4):273-80. PubMed ID: 21599518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
